Intellia Therapeutics

1. nex-z ATTR-CM FDA decision2026nex-z ATTR-CM FDA decision, 2026, thesis-defining
2. lonvo-z BLA filing2H 2026lonvo-z BLA filing, 2H 2026, notable
3. nex-z enrollment done2H 2026nex-z enrollment done, 2H 2026, notable
4. MAGNITUDE ATTR-CM corporate update2H 2026MAGNITUDE ATTR-CM corporate update, 2H 2026, notable
5. lonvo-z commercial launch1H 2027lonvo-z commercial launch, 1H 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.